Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
Gao G, Cui L, Zhou F, Jiang T, Wang W, Mao S, Wu F, Jiang F, Zhang B, Bei T, Xie W, Zhang C, Zhang H, Gao C, Zhao X, Bai Y, Zhou C, Ren S.
Gao G, et al. Among authors: jiang t, jiang f.
Int J Cancer. 2023 Jan 1;152(1):79-89. doi: 10.1002/ijc.34239. Epub 2022 Sep 5.
Int J Cancer. 2023.
PMID: 36062503